StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
VSBC

VitaSpring Biomedical Co. Ltd.

VSBC Services-Commercial Physical & Biological Research EDGAR ↗
$0.01
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$2.30M
Revenue (TTM)
$0.00
Net income (TTM)
-$411K
EPS (TTM)
$0.00
P/E ratio
Dividend yield
Free cash flow
Cash
$8.17K
Total assets
$11.4K
Gross margin
52-week range
$0.01 – $1.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-K Fiscal year ended 2026-01-31 Jun 17, 2026 10-Q Quarter ended 2026-04-30 Jun 17, 2026 10-Q Quarter ended 2025-10-31 Jun 17, 2026 10-Q Quarter ended 2025-07-31 Jun 17, 2026 10-Q Quarter ended 2025-04-30 Jun 15, 2026 10-K Fiscal year ended 2025-01-31 Jun 8, 2026 10-Q Quarter ended 2024-10-31 May 6, 2026 10-Q Quarter ended 2024-07-31 Apr 22, 2026 10-Q Quarter ended 2024-04-30 Apr 2, 2026 10-K Fiscal year ended 2024-01-31 Mar 12, 2026 10-Q Quarter ended 2023-10-31 Jan 30, 2026 10-Q Quarter ended 2023-07-31 Jan 23, 2026 10-Q Quarter ended 2023-04-30 Jan 13, 2026 10-K Fiscal year ended 2023-01-31 Dec 1, 2025 8-K Changed accountants Aug 25, 2025 8-K Changed accountants; Director or officer change Aug 11, 2025 8-K Director or officer change; Other events Jul 29, 2025 8-K Changed accountants Jan 27, 2023 10-Q Quarter ended 2022-10-31 Dec 21, 2022 10-Q Quarter ended 2022-07-31 Sep 15, 2022 10-Q Quarter ended 2022-04-30 Jun 15, 2022 10-K Fiscal year ended 2022-01-31 May 3, 2022 10-Q Quarter ended 2021-10-31 Dec 23, 2021 10-Q Quarter ended 2021-07-31 Sep 15, 2021 8-K Director or officer change Aug 11, 2021 10-Q Quarter ended 2021-04-30 Jun 14, 2021 8-K Entered a material agreement Apr 22, 2021 10-K Fiscal year ended 2021-01-31 Apr 14, 2021 10-Q Quarter ended 2020-10-31 Dec 15, 2020 8-K/A Entered a material agreement Dec 2, 2020 8-K Entered a material agreement Dec 1, 2020 10-Q Quarter ended 2020-07-31 Sep 28, 2020 8-K Unregistered sale of equity; Other events Aug 4, 2020 10-Q Quarter ended 2020-04-30 Jun 19, 2020 10-K Fiscal year ended 2020-01-31 Jun 9, 2020 8-K Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure; Other events Apr 27, 2020 8-K/A Change in control; Director or officer change Feb 26, 2020 8-K Director or officer change Jan 31, 2020 10-Q Quarter ended 2019-10-31 Dec 12, 2019 10-Q Quarter ended 2019-07-31 Aug 27, 2019